期刊文献+

全反式维甲酸对各种人甲状腺肿瘤细胞株增殖、摄碘及甲状腺特异基因表达的影响 被引量:1

Effects of all-trans retinoic acid on proliferation,iodide uptake and thyroid specific gene expression in different cell lines of human thyroid carcinoma
原文传递
导出
摘要 对4种甲状腺癌细胞株予全反式维甲酸处理,四甲基偶氮唑盐法检测细胞增殖,同位素法测定摄碘功能,半定量RT-PCR检测甲状腺特异基因及维甲酸受体表达。结果显示全反式维甲酸可抑制FTC-133细胞增殖,促进其摄碘及甲状腺特异基因的表达,但对C643、HTH74及XTC.UC1细胞无影响,提示不同甲状腺肿瘤细胞对全反式维甲酸的反应性不相同。 Different human thyroid carcinoma cell lines were treated with all-trans retinoic acid (RA). RA could inhibit cell growth, improve iodide uptake and increase some thyroid specific genes and retinoid acid receptor (RAR) mRNA expressions in FTC-133 cells. However, RA had no effect in C643, HTH74 and XTC- UC1 cells. These findings indicate that different thyroid carcinoma cells display diverse responses to RA.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2007年第6期510-511,共2页 Chinese Journal of Endocrinology and Metabolism
基金 江苏省政府医学重点学科项目基金[苏卫科教(2001)34]
关键词 甲状腺肿瘤 维甲酸 增殖 摄碘 受体 维甲酸 Thyroid neoplasms Tretinoin Proliferation Iodide uptake Receptor, retinoid acid
  • 相关文献

参考文献8

  • 1Elisei R, Vivaldi A, Agate L, et al. All-trans-retinoic acid treatment inhibits the growth of retinoic acid receptor beta messenger fibonucleic acid expressing thyroid cancer cell lines but does not reinduce the expression of thyroid-specific genes. J Clin Endocrinol Metab, 2005,90 : 2403-2411.
  • 2Schmutzler C, Hoang-Vu C, Ruger B, et al. Human thyroid carcinoma cell lines show different retinoic acid receptor repertoires and retinoid responses. Eur J Endocrinol, 2004,150:547-556.
  • 3Haugen BR, Larson LL, Pugazhenthi U, et al. Retinoic acid and retinoid X receptors are differentially expressed in thyroid cancer and thyroid carcinoma cell lines and predict response to treatment with retinoids. J Clin Endocrinol Metab, 2004,89:272-280.
  • 4刘超,李倩,段宇,覃又文,刘翠萍,武晓泓,蒋须勤.维甲酸对甲状腺癌细胞钠/碘转运体基因的调节作用[J].中华内分泌代谢杂志,2004,20(4):302-303. 被引量:3
  • 5张一帆,贾士铨,李彪,刘勇,王朝晖,朱承谟.维甲酸诱导分化治疗甲状腺癌的临床研究[J].中华内分泌代谢杂志,2006,22(2):101-104. 被引量:5
  • 6Coelho SM, Vaisman M, Carvalho DP. Turnout re-differentlation effect of retinoic acid: a novel therapeutic approach for advanced thyroid cancer. Curt Pharm Des, 2005,11:2525-2531.
  • 7Liu YY, Stokkel MP, Pereira AM, et al. Bexarotene increases uptake of radioiodide in metastases of differentiated thyroid carcinoma. Eur J Endocfinol, 2006,154:525-531.
  • 8Kurebayashi J, Tanaka K, Otsuki T, et al. All-trans-retinoic acid modulates expression levels of thyroglobulin and cytokines in a new human poorly differentiated papillary thyroid carcinoma cell line, KTC- 1. J Clin Endocfinol Metab, 2000,85:2889-2896.

二级参考文献16

  • 1刘超,李倩,段宇,覃又文,刘翠萍,武晓泓,蒋须勤.维甲酸对甲状腺癌细胞钠/碘转运体基因的调节作用[J].中华内分泌代谢杂志,2004,20(4):302-303. 被引量:3
  • 2Grunwald F, Menzel C, Bender H, et al. Rediffereniation therapy-induced radioiodine uptake in thyroid cancer. J Nucl Med, 1998,39:1903-1906.
  • 3Park HJ, Kim JY, Park KY, et al. Expression of human sodium iodide symporter mRNA in primary and metastatic papillary thyroid carcinomas. Thyroid, 2000,10:211-217.
  • 4Schmutzler C, Kohrle J. Retinoic acid redifferentiation therapy for thyroid cancer. Thyroid, 2000,10:393-406.
  • 5Schreck R, Schnieders F, Schmutzler C, et al. Retinoids stimulate type I iodothyronine 5′-deiodinase activity in human follicular thyroid carcinoma cell lines. J Clin Endocrinol Metab, 1994,79:791-798.
  • 6Bassi V, Vitale Nt Feliciello A, De Riu S, et al. Retinoic acid induces intercellular adhesion molecule-1 hyperexpression in human thyroid carcinoma cell lines. J Clin Endocrinol Metab, 1995,80 : 1129-1135.
  • 7Dohan O, De La Vieja A, Carrasco N. Molecular study of the sodium/iodide symporter (NIS) : a new field in thyroidology. Trends Endocrinol Metab, 2000,11:99-105.
  • 8Goretzki PE, Simon D, Frilling A, et al. Surgical reintervention for differentiated thyroid carcinoma. Br J Surg, 1994,80 : 1131-1134.
  • 9Simon D, Korber C, Krausch M, et al. Clinical impact of retinoids in redifferentiation therapy of advanced thyroid cancer: final results of a pilot study. Eur J Nucl Med Imaging, 2002,29:775-782.
  • 10Hansen LA, Sigman CC, Andreola F, et al. Retinoids in chemoprevention and differentiation therapy. Carcinogenesis, 2000,21 : 1271-1279.

共引文献6

同被引文献21

  • 1蔺林,窦拉加,张成武,杨守仁.尿纤溶酶原激活物和整合素在甲状腺癌组织中的表达[J].中国耳鼻咽喉头颈外科,2007,14(5):291-293. 被引量:3
  • 2Clark DP,Faquin WC.Thyroid cytopathology.Baltimore:Rosenthal DL,2005,38-43.
  • 3Seriui G,Trusolino L,Saqqiorato E,et al.Changes in Integrin and E-Cadherin Expression in Neoplastic Versus Normal Thyroid Tissue.J Natl Cancer lnst,1996,88:442-449.
  • 4Kitajiri S,Hosaka N,Hiraumi H.Increased expression of integrin-4 in papillary thyroid carcinoma with gross lymph nod metastasis.Pathology International,2002,52:438-441.
  • 5Albini A,Lwamoto Y,Klerrnman HK,et al.A rapad invitro assay for quantitating the invasive potential of tumor cells.Cancer Res,1987,47:3239-3245.
  • 6Hynes RO.Integrins:bidirectional,allosteric signaling machines.Cell,2002,110:673-687.
  • 7Hemler ME,Crouse C,Sonnenberg A.Association of the VLA alpha 6 subunit with a novel protein.A possible alternative to the common VLA beta 1 subunit on certain cell lines.J Biol Chem,1989,264:6529-6535.
  • 8Nikolopoulos SN,Blaikie P,Yoshioka T,et al.Integrin beta4 signaling promotes tumor angiogenesis.Cancer Cell,2004,6:471-483.
  • 9Abdel-Ghany M,Cheng HC,Elbler C,et al.The breast cancer B4 integrin and endothelial human CLCA2 mediated lung metastasis.J Boil Chem,2001,276:2538-2551.
  • 10Akira K,Masaki N,Nobutaka K,et al.Diagnostic value of integrin alpha3,beta4,and beta5 gene expression levels for the clinical outcome of tongue squamous cell carcinoma.J Cancer,2008,112:1272-1281.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部